US SB1323 | 2021-2022 | 117th Congress

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on April 22 2021 - 25% progression
Action: 2021-04-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

End Price Gouging for Medications Act

Sponsors


History

DateChamberAction
2021-04-22SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB2829 (Same As) 2021-07-14 - Referred to the Subcommittee on Health.

Subjects


US Congress State Sources


Bill Comments 750

feedback